Related Experiment Video
Updated: Jul 29, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mid-term outcomes following the Hemi-Commando procedure for complex infective endocarditis involving the aortomitral
Mateo Marin-Cuartas1, Manuela De La Cuesta1, Piroze M Davierwala2
1University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
Objectives:
Perivalvular abscesses with destruction of the aortomitral junction (AMJ) are a severe complication of infective endocarditis (IE) and are associated with high mortality and complex management. The Hemi-Commando procedure is a mitral valve-sparing alternative to the Commando procedure in suitable patients with complex IE and paravalvular destruction. This study reviews the mid-term outcomes in patients undergoing the Hemi-Commando procedure for treating IE with destruction of the AMJ.
Methods:
The clinical outcomes of patients with IE and AMJ involvement who underwent the Hemi-Commando procedure between 2015 and 2021 at the Leipzig Heart Center were retrospectively analysed. Primary outcomes were 30-day mortality and 1-year survival. Secondary outcome was 1-year freedom from reoperation.
Results:
A total of 22 patients underwent the Hemi-Commando procedure during the study period. The patients' mean age was 59.8 ± 18.3 years. The study population was predominantly male (86.4%). Preoperative sepsis was present in 6 (27.3%) patients, and the median EuroSCORE II was 28.5%. Almost two-thirds (N = 14; 63.6%) of the patients presented with native IE. Streptococci were the most common pathogens (N = 8; 36.4%). Paravalvular abscess was found intraoperatively in 16 (72.7%) patients. The 30-day mortality was 13.6%. The estimated 1- and 3-year survival rates were 77.5% and 66.4%, respectively. The estimated freedom from reoperation at 1 and 3 years was 92.3%.
Conclusions:
The Hemi-Commando procedure offers an acceptable mid-term survival chance with low reoperation rates and is, therefore, a reasonable mitral valve-sparing alternative to the Commando procedure in suitable patients with extensive IE and perivalvular involvement.
Insights
The Hemi-Commando procedure provides a viable mitral valve-sparing option for complex infective endocarditis (IE) involving the aortomitral junction (AMJ). Mid-term outcomes show acceptable survival and low reoperation rates, making it an alternative to the Commando procedure.
Area of Science:
- Cardiovascular Surgery
- Infective Endocarditis Research
- Cardiac Valve Repair
Background:
- Perivalvular abscesses with aortomitral junction (AMJ) destruction are severe infective endocarditis (IE) complications.
- These conditions are linked to high mortality and complex treatment challenges.
- The Hemi-Commando procedure is a mitral valve-sparing alternative for specific IE cases.
Purpose of the Study:
- To review mid-term outcomes of the Hemi-Commando procedure in patients with IE and AMJ destruction.
- To evaluate the efficacy and safety of this valve-sparing approach.
- To compare its outcomes against traditional methods.
Main Methods:
- Retrospective analysis of clinical outcomes for 22 patients.
- Patients underwent the Hemi-Commando procedure between 2015 and 2021.
- Primary outcomes included 30-day mortality and 1-year survival; secondary outcome was 1-year freedom from reoperation.
Main Results:
- The 30-day mortality rate was 13.6%.
- Estimated 1- and 3-year survival rates were 77.5% and 66.4%, respectively.
- Estimated freedom from reoperation at 1 and 3 years was 92.3%.
Conclusions:
- The Hemi-Commando procedure demonstrates acceptable mid-term survival.
- It is associated with low reoperation rates.
- It represents a reasonable mitral valve-sparing alternative for extensive IE with perivalvular involvement.
Related Concept Videos
Endocarditis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management

